HK1128077A1 - Intranasal influenza vaccine based on virosomes - Google Patents

Intranasal influenza vaccine based on virosomes

Info

Publication number
HK1128077A1
HK1128077A1 HK09105522.7A HK09105522A HK1128077A1 HK 1128077 A1 HK1128077 A1 HK 1128077A1 HK 09105522 A HK09105522 A HK 09105522A HK 1128077 A1 HK1128077 A1 HK 1128077A1
Authority
HK
Hong Kong
Prior art keywords
virosomes
influenza vaccine
vaccine based
intranasal influenza
intranasal
Prior art date
Application number
HK09105522.7A
Inventor
Alexander J Kersten
Lisya Gerez
Pieter J Schoen
Jozef J P Nauta
Dorine H Van Rheineck Leyssius
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2007/052690 external-priority patent/WO2007107585A1/en
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Publication of HK1128077A1 publication Critical patent/HK1128077A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HK09105522.7A 2006-03-22 2009-06-19 Intranasal influenza vaccine based on virosomes HK1128077A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06111534 2006-03-22
PCT/EP2007/052690 WO2007107585A1 (en) 2006-03-22 2007-03-21 Intranasal influenza vaccine based on virosomes

Publications (1)

Publication Number Publication Date
HK1128077A1 true HK1128077A1 (en) 2009-10-16

Family

ID=36648714

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105522.7A HK1128077A1 (en) 2006-03-22 2009-06-19 Intranasal influenza vaccine based on virosomes

Country Status (6)

Country Link
CN (2) CN101405027B (en)
HK (1) HK1128077A1 (en)
MX (1) MX2008012046A (en)
TW (1) TWI397419B (en)
UA (1) UA93236C2 (en)
ZA (1) ZA200807880B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107375920B (en) * 2017-06-23 2020-08-11 中农威特生物科技股份有限公司 Porcine reproductive and respiratory syndrome virus-swine influenza virus reconstituted virosome vaccine and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919243A1 (en) * 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
AR056245A1 (en) * 2003-06-19 2007-10-03 Bestewil Holding Bv FUNCTIONAL RECONSTITUTED VIRAL MEMBRANES CONTAINING A COADYUVANT

Also Published As

Publication number Publication date
CN102580077A (en) 2012-07-18
CN101405027B (en) 2013-01-02
TWI397419B (en) 2013-06-01
TW200808345A (en) 2008-02-16
UA93236C2 (en) 2011-01-25
CN101405027A (en) 2009-04-08
MX2008012046A (en) 2009-01-22
ZA200807880B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
IL196024A0 (en) Influenza vaccine
HK1143085A1 (en) Low-additive influenza vaccines
SI2422810T1 (en) Influenza vaccine
GB0810305D0 (en) Influenza vaccination
ZA200810582B (en) Adjuvant-sparing multi-dose influenza vaccination regimen
SI1942933T1 (en) Canine influenza vaccines
EP1998814A4 (en) Novel influenza m2 vaccines
PL2358386T3 (en) Optimized influenza vaccines
ZA200809056B (en) Influenza virus vaccine
HK1214534A1 (en) Influenza vaccination
ZA201100962B (en) Influenza vaccines
EP2097103A4 (en) Influenza vaccine formulation
EP2368899B8 (en) Avian influenza vaccine
IL193840A0 (en) Intranasal influenza vaccine based on virosomes
HK1128077A1 (en) Intranasal influenza vaccine based on virosomes
EP2240199A4 (en) Influenza b vaccines
ZA200900062B (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine
GB0625453D0 (en) Influenza vaccine
GB0623218D0 (en) Influenza vaccine
GB0619090D0 (en) Influenza vaccine
GB0618195D0 (en) Influenza vaccine
IL191977A0 (en) Improved influenza vaccine
GB0723987D0 (en) Influenza vaccine reagents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170321